業績紹介

2014年 論文

  • The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ? 50 years.
    Kosaka T, Mizuno R, Shinojima T, Miyajima A, Kikuchi E, Tanaka N, Shinoda K, Morita S, Mikami S, Oya M.
    Am J Clin Exp Urol. 2014 Dec 25;2(4):332-6. eCollection 2014.
  • Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancer.
    Hongo H, Kosaka T, Oya M.
    Can Urol Assoc J. 2014 Nov;8(11-12):E921-3.
  • Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin.
    Ide H, Kikuchi E, Mikami S, Miyajima A, Oya M.
    BMC Res Notes. 2014 Sep 13;7:646.
  • Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer.
    Hongo H, Kosaka T, Oya M.
    Urol Case Rep. 2014 Jul 19;2(5):150-1.
  • Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer.
    Kosaka T, Miyajima A, Yasumizu Y, Miyazaki Y, Kikuchi E, Oya M.
    Steroids. 2014 Dec;92:39-44.
  • Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan.
    Onozawa M, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y, Akaza H.
    Jpn J Clin Oncol. 2014 Oct;44(10):969-81.
  • A case of bladder-inverted papilloma after brachytherapy for prostate cancer.
    Ezaki T, Kosaka T, Mikami S, Kaburaki N, Mizuno R, Oya M.
    Case Rep Nephrol Urol. 2014 Jun 28;4(2):131-6.
  • Individualized prostate-specific antigen threshold values to avoid overdiagnosis of prostate cancer and reduce unnecessary biopsy in elderly men.
    Kanao K, Komori O, Nakashima J, Ohigashi T, Kikuchi E, Miyajima A, Nakagawa K, Eguchi S, Oya M.
    Jpn J Clin Oncol. 2014 Sep;44(9):852-9.
  • Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.
    Oguchi H, Sasamura H, Shinoda K, Morita S, Kono H, Nakagawa K, Ishiguro K, Hayashi K, Nakamura M, Azegami T, Oya M, Itoh H.
    Hypertension. 2014 Oct;64(4):784-91.
  • Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy.
    Matsumoto K, Mizuno R, Tanaka N, Ide H, Hasegawa M, Ishida M, Hayakawa N, Yasumizu Y, Hagiwara M, Hara S, Kikuchi E, Miyajima A, Nakagawa K, Nakajima Y, Nakamura S, Nakashima J, Oya M. Med Oncol. 2014 Jul;31(7):45.
  • A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Miyazaki Y, Kobayashi H, Kaneko G, Hagiwara M, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Hara S, Oyama M, Momma T, Nakajima Y, Jinzaki M, Oya M.
    Ann Surg Oncol. 2014 Nov;21(12):4041-8.
  • Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material.
    Akita H, Jinzaki M, Akita A, Mikami S, Oya M, Kuribayashi S.
    J Magn Reson Imaging. 2014 Apr;39(4):924-30.
  • The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Oyama M, Miyajima A, Momma T, Nakagawa K, Jinzaki M, Nakajima Y, Oya M.
    Urol Oncol. 2014 Jan;32(1):48.e19-26.
  • Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5α-reductase inhibitors.
    Kosaka T, Yasumizu Y, Miyazaki Y, Miyajima A, Kikuchi E, Oya M.
    Am J Clin Exp Urol. 2014 Jul 12;2(2):136-44.
  • Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?
    Kosaka T, Miyajima A, Oya M.
    Front Oncol. 2014 Sep 16;4:247. doi: 10.3389/fonc.2014.00247. eCollection 2014. Review.
  • Unidirectional barbed suture for vesicourethral anastomosis during laparoscopic radical prostatectomy.
    Takeda T, Miyajima A, Kaneko G, Hasegawa M, Kikuchi E, Oya M.
    Asian J Endosc Surg. 2014 Aug;7(3):241-5.
  • Laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: a comparison of surgical outcomes and an analysis of a single surgeon's learning curve.
    Hirasawa Y, Miyajima A, Hattori S, Miyashita K, Kurihara I, Shibata H, Kikuchi E, Nakagawa K, Oya M.
    Surg Endosc. 2014 Oct;28(10):2911-9.
  • A case of bladder cancer after radiation therapy for prostate cancer.
    Kaburaki N, Kosaka T, Yazawa S, Oya M.
    Case Rep Nephrol Urol. 2014 Mar 27;4(1):53-9.
  • Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
  • Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Hagiwara M, Kosaka T, Oyama M, Miyajima A, Momma T, Nakagawa K, Jinzaki M, Hasegawa S, Nakajima Y, Oya M. Ann Surg Oncol. 2014 Sep;21(9):3151-8.
  • Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor.
    Mizuno R, Miyajima A, Oya M.
    Int J Urol. 2014 Jul;21(7):740.
  • The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
    Tanaka N, Kikuchi E, Shirotake S, Kanao K, Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Ito Y, Kosaka T, Kodaira K, Oyama M, Miyajima A, Momma T, Nakagawa K, Ueno M, Oya M.
    Eur Urol. 2014 Jan;65(1):227-34.
  • Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study. Togo Y, Kubo T, Taoka R, Hiyama Y, Uehara T, Hashimoto J, Kurimura Y, Takahashi S, Tsukamoto T, Miyazaki J, Nishiyama H, Kira S, Kiyota H, Yazawa S, Niwa N, Hongo H, Oya M, Kato T, Yasuda M, Deguchi T, Ishikawa K, Hoshinaga K, Matsumoto M, Shigemura K, Tanaka K, Arakawa S, Fujisawa M, Wada K, Uehara S, Watanabe T, Kumon H, Kobayashi K, Matsubara A, Matsumoto M, Sho T, Hamasuna R, Matsumoto T, Hayami H, Nakagawa M, Yamamoto S.
    J Infect Chemother. 2014 Apr;20(4):232-7. doi: 10.1016/j.jiac.2013.10.003. Epub 2013 Dec 11. Erratum in: J Infect Chemother. 2014 Oct;20(10):660.
  • Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management.
    Jinzaki M, Silverman SG, Akita H, Nagashima Y, Mikami S, Oya M.
    Abdom Imaging. 2014 Jun;39(3):588-604.
  • Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma.
    Hattori S, Miyajima A, Hirasawa Y, Kikuchi E, Kurihara I, Miyashita K, Shibata H, Nakagawa K, Oya M.
    J Endourol. 2014 Jun;28(6):686-92.
  • Androgen deprivation therapy improves pneumoperitoneum time during laparoscopic radical prostatectomy in Japanese patients with enlarged prostates.
    Takeda T, Miyajima A, Kaneko G, Kikuchi E, Nakagawa K, Oya M.
    Asian J Endosc Surg. 2014 May;7(2):145-51. doi: 10.1111/ases.12084. Epub 2014 Jan 14.
  • Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression.
    Kobayashi H, Kikuchi E, Mikami S, Maeda T, Tanaka N, Miyajima A, Nakagawa K, Oya M.
    BMC Urol. 2014 Jan 8;14:5.
  • Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Kobayashi H, Ide H, Miyazaki Y, Obata J, Hoshino K, Shirotake S, Akita H, Kosaka T, Miyajima A, Momma T, Nakagawa K, Hasegawa S, Nakajima Y, Jinzaki M, Oya M.
    Ann Surg Oncol. 2014 Mar;21(3):1038-45.
  • Invasion and metastasis of renal cell carcinoma.
    Mikami S, Oya M, Mizuno R, Kosaka T, Katsube K, Okada Y.
    Med Mol Morphol. 2014 Jun;47(2):63-7.
  • Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer.
    Yasumizu Y, Miyajima A, Kosaka T, Miyazaki Y, Kikuchi E, Oya M.
    J Urol. 2014 Jan;191(1):227-34.
  • Prognostic value of preoperative multiparametric magnetic resonance imaging (MRI) for predicting biochemical recurrence after radical prostatectomy.
    Hattori S, Kosaka T, Mizuno R, Kanao K, Miyajima A, Yasumizu Y, Yazawa S, Nagata H, Kikuchi E, Mikami S, Jinzaki M, Nakagawa K, Tanimoto A, Oya M.
    BJU Int. 2014 May;113(5):741-7. doi: 10.1111/bju.12329. Epub 2013 Aug 13.
業績紹介